NeoGenomics (NEO) shares soared 6.3% in the last trading session to close at $9.97. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 17.4% gain over the past four weeks.This rise in share price is attributable to positive investor expectations around the company’s diagnostics business. At the upcoming ESMO 2025 medical conference, NeoGenomics is set to showcase new clinical data and ongoing interventional studies for its RaDaR ST ...